Search clinical trials for: valsartan (ARB)

Total 4922 results

Nantou Christian Hospital

Completed

Effect of Adding Renin-Angiotensin System Inhibitors to Standard Antidiabetic Therapy on Glycemic Control in Patients With Type 2 Diabetes Ellitus

Diabetes Mellitus, Type 2

Taiwan
Federico II University

Completed

Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Patients With Slight Hypertension and Target Organ Damage

Hypertension | Ventricular Remodeling | Erectile Dysfunctions

Italy
University of Pavia

Unknown

Valsartan and Amlodipine Compared to Losartan and Amlodipine in Hypertensive Patients

Essential Hypertension

Italy
University Medical Centre Ljubljana

Completed

Preventive Arterial Wall Phenotype and Low-dose Fluvastatin/Valsartan Combination (AGE-ZT)

Atherosclerosis
Nantes University Hospital

Terminated

Anti-Proteinuric Response to ACEI, ARB and Diuretics Combination.

Heavy Proteinuria

France
Novartis

Completed

Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)

Hypertension

Japan
Genuine Research Center, Egypt
Pharmacare PLC, Palestine

Completed

A Bioequivalence Study of Amlodipine / Valsartan From Amlodipine/Valsartan 10/160 Tablets (Pharmacare, Palestine) and Exforge Tablets (Novartis Pharma, USA)

Healthy

Egypt
Chinese University of Hong Kong

Terminated

Bedtime ACEIs/ARBs Versus Morning ACEIs/ARBs for Reverting Non-dipping Hypertension

Hypertension | Non-Dipping

Hong Kong
Saitama Medical University

Completed

Effects of Angiotensin Receptor Antagonist on Prohibiting Cardiovascular Events on Hemodialysis Patients

Cardiovascular Disease
Second Affiliated Hospital of Wenzhou Medical University

Unknown

A Bioequivalence Study of Valsartan / Amlodipine From Valsartan and Amlodipine Tablets (Hua Yuan Pharmaceutical LLC, China) and Valsartan and Amlodipine Tablets (Ⅰ) (Novartis Pharma Schweiz AG, Switzerland) (ABSVAFVATVAT)

Healthy

China
Novartis

Completed

The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy (EXTRA)

Hypertension

United States
TSH Biopharm Corporation Limited

Completed

PMS Study of Amlodipine/Valsartan for the Treatment of Hypertension

Essential Hypertension

Taiwan
University Hospital, Basel, Switzerland

Completed

RAS-Peptide-Profile Study in Healthy Male Subjects (RAS)

RAS Peptide Profile in Healthy Volunteers

Switzerland
AEterna Zentaris

Completed

Investigation of a New, Oral Growth Hormone Secretagogue, AEZS-130 as a Growth Hormone Stimulation Test.

Diagnosis of Adult Growth Hormone Deficiency (AGDH)

United States
Mario Negri Institute for Pharmacological Research
Agenzia Italiana del Farmaco

Completed

Preventing ESRD in Overt Nephropathy of Type 2 Diabetes (VALID)

Diabetes

Italy, Slovenia
Takeda

Completed

Azilsartan Medoxomil (TAK-491) Compared to Valsartan in Chinese Participants With Hypertension

Essential Hypertension

China
University Medical Centre Ljubljana

Completed

Post- Myocardial Infarction Arterial Wall Improvement by Low-dose Fluvastatin and Valsartan

Myocardial Infarction

Slovenia
Mustafa Kemal University
Novartis Pharmaceuticals

Completed

Effect of Valsartan on Left Ventricular Myocardial Functions in Hypertensive Patients With Left Ventricular Hypertrophy

Hypertension | Left Ventricular Hypertrophy

Turkey
Shanghai Jiao Tong University School of Medicine

Recruiting

Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy.

Hypertension | Left Ventricular Hypertrophy

China
Novartis Pharmaceuticals

Completed

Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension

Hypertension

Czech Republic, Finland, France, Germany, Hungary, Italy, Poland, Slovakia, Spain, Sweden
Hamilton Health Sciences Corporation

Completed

Angiotensin Converting Enzyme Inhibitors & Contrast Induced Nephropathy in Patients Receiving a Cardiac Catheterization

Kidney Failure

Canada
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Investigation of 9 Consecutive Infusions of Remicade for Psoriatic Arthritis in Austria (Study P04264)

Arthritis, Psoriatic
Brigham and Women's Hospital

Active, not recruiting

Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty

Frailty | Heart Failure, Systolic

United States
EMS

Withdrawn

Fixed-dose Combination of Valsartan + Rosuvastatin Versus Their Isolated Components for Hypertension and Dyslipidemia.

Hypertension | Dyslipidemia
HK inno.N Corporation

Completed

Phase I Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg and Novartis Exforge 10/160mg

Healthy

Korea, Republic of
Mario Negri Institute for Pharmacological Research
Agenzia Italiana del Farmaco

Completed

Preventing Microalbuminuria in Type 2 Diabetes (VARIETY)

Diabetes

Italy
HK inno.N Corporation

Completed

Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With Hyperlipidemia

Hypertension With Hyperlipidemia
Yonsei University

Completed

Randomized, Open Labeled Clinical Trial to Compare the Effectiveness of Amlodipine/Valsartan vs Hydrochlorothiazide/Telmisartan on Glucose Tolerance in Patients With Hypertension With Metabolic Syndrome

Hypertension

Korea, Republic of
Medical Center Alkmaar

Unknown

Dipeptide Alanyl Glutamine and Postoperative Insulin Resistance in Colon Carcinoma Patients (AIRCo)

Colon Carcinoma

Netherlands
Damanhour University

Completed

Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide (Double Doses) (PKVH PART II)

Healthy Normotensive Participants
Novartis

Completed

Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone

Hypertension

Switzerland, Germany
Novartis

Completed

Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension

Hypertension

United States
Novartis

Completed

VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil

Hypertension

Switzerland, Germany
Novartis

Completed

A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.

Hypertension

United States
Novartis

Completed

Long Term Study of VAH631 in Patients With Essential Hypertension (Extension From B1303 Study)

Hypertension
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.

Hypertension

United States
Novartis

Completed

Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan+/-Hydrochlorothiazide (HCTZ) at 6 Months

Hypertension

Singapore
University of Sao Paulo General Hospital
InCor Heart Institute

Recruiting

Angiotensin Receptor-Neprilysin Inhibition in Chagas Cardiomyopathy With Reduced Ejection Fraction: ANSWER-HF. (ANSWER-HF)

Chagas Cardiomyopathy

Brazil
Novartis

Completed

Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension

Essential Hypertension
University of California, Davis
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Suspended

Single-tracer Multiparametric PET Imaging

Cardiovascular Disease | Healthy Subjects

United States
Centre de Recherche de l'Institut Universitaire...

Active, not recruiting

Characterization of RadiOlabeled Tracer Uptake Pattern in Noninfected Transcatheter Aortic Valves. (COUNT)

Infective Endocarditis

Canada
HK inno.N Corporation

Completed

Phase Ⅰ Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg Tablet and Novartis Exforge 10/160mg Tablet

Healthy
State University of New York - Downstate Medical...

Terminated

ACEI/ARB Study in Ambulatory and Day of Surgery Admission Patients (ACE/ARB)

Hypertension | Hypotension

United States
Novartis

Completed

A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome

METABOLIC SYNDROME | HYPERTENSION | PRE-HYPERTENSION

United States
JW Pharmaceutical

Completed

Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia (COCTAIL)

Hypertension | Dyslipidemia

Korea, Republic of
Novartis

Completed

Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension

Hypertension

United States
Hôpital NOVO

Completed

Evaluation of Positioning Protocols on a Wheelchair in Hemiplegic Patients (POSIT-HEMI)

Hemiplegia and/or Hemiparesis Following Stroke

France
National Institute of Allergy and Infectious Diseases...

Not yet recruiting

A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission

Acute HIV Infection

United States, Brazil, Peru
Novartis

Completed

Hypertension and Cardiovascular Risk Factors

HYPERTENSION
Boryung Pharmaceutical Co., Ltd
Chonnam National University Hospital; Seoul National University Hospital; Kyungpook... and other collaborators

Completed

A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential Hypertension

Essential Hypertension

3

Subscribe